| Date Filed | Type | Description |
| 08/14/2023 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 393,750 options to buy
@ $1.36, valued at
$535.5k
|
|
| 01/17/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 480,000 options to buy
@ $0.26, valued at
$124.8k
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 876 shares
@ $0.5211, valued at
$456.5 |
|
| 08/17/2020 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 872 shares
@ $0.605, valued at
$527.6 |
|
| 05/18/2020 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 909 shares
@ $0.6268, valued at
$569.8 |
|
| 02/19/2020 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 888 shares
@ $0.8305, valued at
$737.5 |
|
| 01/24/2020 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 210,000 options to buy
@ $1.31, valued at
$275.1k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 335,000 options to buy
@ $0.64, valued at
$214.4k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2019 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 899 shares
@ $0.5506, valued at
$495 |
|
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2019 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 38,512 shares
@ $0
Sold 6,950 shares
@ $1.4095, valued at
$9.8k
Granted 7,500 options to buy
@ $0.95, valued at
$7.1k
|
|
| 04/03/2019 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 2,710 shares
@ $0.9812, valued at
$2.7k
|
|
| 02/06/2019 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 25,000 options to buy
@ $0.95, valued at
$23.8k
|
|
| 01/02/2019 |
3
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 3 on Regulus Therapeutics Inc. |